213 related articles for article (PubMed ID: 3580268)
1. Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.
Owainati AA; Robins RA; Hinton C; Ellis IO; Dowle CS; Ferry B; Elston CW; Blamey RW; Baldwin RW
Br J Cancer; 1987 Apr; 55(4):449-54. PubMed ID: 3580268
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the DNA content of human breast cancer.
Dowle CS; Owainati A; Robins A; Burns K; Ellis IO; Elston CW; Blamey RW
Br J Surg; 1987 Feb; 74(2):133-6. PubMed ID: 3815031
[TBL] [Abstract][Full Text] [Related]
3. Steroid receptor heterogeneity in relation to DNA index in breast cancer: a multiparameter flow cytometric approach on paraffin-embedded tumor samples.
Leers MP; Nap M
Breast J; 2001; 7(4):249-59. PubMed ID: 11678803
[TBL] [Abstract][Full Text] [Related]
4. Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.
Pinto AE; Pereira T; Silva GL; André S
Breast; 2015 Aug; 24(4):449-55. PubMed ID: 25920680
[TBL] [Abstract][Full Text] [Related]
5. Relationship between DNA ploidy and survival in patients with primary breast cancer.
Eskelinen MJ; Pajarinen P; Collan Y; Pesonen E; Alhava E; Kettunen K; Nordling S
Br J Surg; 1989 Aug; 76(8):830-4. PubMed ID: 2765840
[TBL] [Abstract][Full Text] [Related]
6. Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer.
Kallioniemi OP; Hietanen T; Mattila J; Lehtinen M; Lauslahti K; Koivula T
Eur J Cancer Clin Oncol; 1987 Mar; 23(3):277-82. PubMed ID: 3595689
[TBL] [Abstract][Full Text] [Related]
7. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer.
Yildirim-Assaf S; Coumbos A; Hopfenmüller W; Foss HD; Stein H; Kühn W
J Clin Pathol; 2007 Jun; 60(6):649-55. PubMed ID: 17557867
[TBL] [Abstract][Full Text] [Related]
9. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy and survival in breast cancer patients.
Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
[TBL] [Abstract][Full Text] [Related]
11. Predicting outcome for patients with node negative breast cancer: a comparative study of the value of flow cytometry and cell image analysis for determination of DNA ploidy.
Yuan J; Hennessy C; Givan AL; Corbett IP; Henry JA; Sherbet GV; Lennard TW
Br J Cancer; 1992 Mar; 65(3):461-5. PubMed ID: 1348424
[TBL] [Abstract][Full Text] [Related]
12. Tumour DNA ploidy as an independent prognostic factor in breast cancer.
Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Koivula T
Br J Cancer; 1987 Nov; 56(5):637-42. PubMed ID: 3426929
[TBL] [Abstract][Full Text] [Related]
13. DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters.
Redkar AA; Balsara BR; Bhisey AN; Sampat MB; Mittra I
Indian J Med Res; 1992 Aug; 96():223-9. PubMed ID: 1428060
[TBL] [Abstract][Full Text] [Related]
14. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.
Hedley DW; Friedlander ML; Taylor IW
Cytometry; 1985 Jul; 6(4):327-33. PubMed ID: 4017799
[TBL] [Abstract][Full Text] [Related]
15. Aneuploid subpopulations in tumour-invaded lymph nodes from breast cancer patients.
Alam SM; Whitford P; Cushley W; George WD; Campbell AM
Eur J Cancer; 1992; 28(2-3):357-62. PubMed ID: 1375482
[TBL] [Abstract][Full Text] [Related]
16. Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer.
Leers MP; Schoffelen RH; Hoop JG; Theunissen PH; Oosterhuis JW; vd Bijl H; Rahmy A; Tan W; Nap M
J Clin Pathol; 2002 May; 55(5):359-66. PubMed ID: 11986342
[TBL] [Abstract][Full Text] [Related]
17. Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer.
Horsfall DJ; Tilley WD; Orell SR; Marshall VR; Cant EL
Br J Cancer; 1986 Jan; 53(1):23-8. PubMed ID: 3004547
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
19. Comparison study of DNA content of primary and metastatic lymph node lesions of colorectal cancer.
Vijayan V; Ho J; Goh HS
Ann Acad Med Singap; 1995 May; 24(3):347-52. PubMed ID: 7574412
[TBL] [Abstract][Full Text] [Related]
20. DNA index, S-phase fraction, histological grade and prognosis in breast cancer.
O'Reilly SM; Camplejohn RS; Barnes DM; Millis RR; Allen D; Rubens RD; Richards MA
Br J Cancer; 1990 May; 61(5):671-4. PubMed ID: 2159768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
